Stay updated on Belantamab in Multiple Myeloma Clinical Trial
Sign up to get notified when there's something new on the Belantamab in Multiple Myeloma Clinical Trial page.
Latest updates to the Belantamab in Multiple Myeloma Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedA new revision entry v3.4.2 was added to the history, and a government-funding operating-status notice and the prior revision v3.4.1 were removed.SummaryDifference0.7%
- Check21 days agoChange DetectedAdded a government funding notice indicating potential delays and status updates, and updated the record revision from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.7%
- Check28 days agoChange DetectedThe history page updates include UI enhancements such as displaying the glossary and color-coded additions/deletions as well as a new revision label (v3.4.0); these changes affect presentation rather than the study data.SummaryDifference0.9%
- Check42 days agoChange DetectedA new revision entry v3.3.4 has been added and the previous revision entry v3.3.3 has been removed from the record history.SummaryDifference0.1%
- Check64 days agoChange DetectedA new revision entry v3.3.3 was added, and the footer item for 'HHS Vulnerability Disclosure' as well as the old 'Revision: v3.3.2' were removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%
- Check78 days agoChange DetectedDifference0.8%
Stay in the know with updates to Belantamab in Multiple Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Belantamab in Multiple Myeloma Clinical Trial page.